ClinicalTrials.Veeva

Menu

Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney Injury (MyDAKI-01)

U

University of Saskatchewan

Status

Completed

Conditions

Acute Kidney Injury
Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT01924663
MyDAKI-01

Details and patient eligibility

About

The purpose of this study is to be able to better describe the incidence, timing and severity of myocardial dysfunction and acute kidney injury (AKI) following a documented respiratory viral illness (RSV, adenovirus, metapneumovirus, parainfluenza, influenza, etc.) in pediatric patients.

Full description

This is a single-centre, prospective and retrospective, descriptive data-collection pilot study.

Prospective Data Collection:

All pediatric patients who are less than 18 years with a confirmed positive respiratory viral swab will be invited to participate.

Retrospective Data Collection:

The retrospective portion of this study will examine a 5 year period prior to the start of enrollment for the prospective study, with the intention to include all pediatric patients who are less than 18 years with a confirmed positive respiratory viral swab and admitted into the local hospital's PICU.

Enrollment

21 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The parent or legal guardian of the pediatric subject must sign the Consent Form for participants in the prospective portion of the study.
  2. The subject must be no greater than 18 years of age, at the time of consent.
  3. The subject must be admitted to the local hospital.
  4. The subject must have a confirmed positive respiratory viral swab.

Exclusion criteria

  1. The parent or legal guardian of the pediatric subject is unavailable or unwilling to sign the Consent Form for participants in the prospective portion of the study.
  2. The subject has had previous kidney injury or myocardial dysfunction prior to positive respiratory viral swab.
  3. The subject has any previous problems (prior to positive respiratory viral swab) with their heart or kidneys that could compromise the results, in the opinion of the Investigator.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems